Asset Planning Services (Pennsylvania)’s iShares Biotechnology ETF IBB Stock Holding History

Asset Planning Services (Pennsylvania)’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-344	Closed	-$34K	–	155
2019 Q3	$34K	Hold	344	–	–	0.01%	150
2019 Q2	$38K	Hold	344	–	–	0.02%	144
2019 Q1	$38K	Hold	344	–	–	0.02%	144
2018 Q4	$33K	Hold	344	–	–	0.02%	144
2018 Q3	$38K	Buy	344 +1	+0.3%	+$118	0.02%	141
2018 Q2	$38K	Hold	343	–	–	0.02%	143
2018 Q1	$37K	Hold	343	–	–	0.02%	144
2017 Q4	$37K	Sell	343 -404	-54%	-$43.2K	0.02%	148
2017 Q3	$83K	Buy	747 +201	+37%	+$21.5K	0.05%	114
2017 Q2	$56K	Buy	546 +297	+119%	+$29.3K	0.04%	132
2017 Q1	$24K	Buy	+249	New	+$23.8K	0.02%	180

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Asset Planning Services (Pennsylvania)'s IBB Position: Q4 2019 in Review

Asset Planning Services (Pennsylvania) sold out of iShares Biotechnology ETF (IBB) in Q4 2019, closing a stake of 344 shares — an estimated $34K sold.

Asset Planning Services (Pennsylvania) first reported a position in IBB in Q1 2017 and held it in 11 quarters. The position peaked at $83K in Q3 2017. 710 funds tracked by Wall St. Rank hold IBB as of Q4 2019.

Asset Planning Services (Pennsylvania) reported no remaining iShares Biotechnology ETF position as of Q4 2019 after selling out during the quarter.
Asset Planning Services (Pennsylvania) sold 344 iShares Biotechnology ETF shares in Q4 2019, an estimated $34K.
Asset Planning Services (Pennsylvania) first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 11 quarters.
Asset Planning Services (Pennsylvania)'s iShares Biotechnology ETF position peaked at $83K in Q3 2017.
710 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2019.

Based on Asset Planning Services (Pennsylvania)'s 13F filing for Q4 2019, filed 12 Feb 2020.